|
ALKS
|
Alkermes plc
|
US
|
NASDAQ
|
|
ATXI
|
Avenue Therapeutics, Inc.
|
US
|
NASDAQ
|
|
BCLI
|
Brainstorm Cell Therapeutics Inc.
|
US
|
NASDAQ
|
|
BXRX
|
Baudax Bio, Inc.
|
US
|
NASDAQ
|
|
CYBN
|
Cybin Inc.
|
US
|
AMEX
|
|
KTTA
|
Pasithea Therapeutics Corp.
|
US
|
NASDAQ
|
|
NERV
|
Minerva Neurosciences, Inc
|
US
|
NASDAQ
|
|
OI
|
Owens-Illinois, Inc.
|
US
|
NYSE
|
|
OYST
|
Oyster Point Pharma, Inc.
|
US
|
NASDAQ
|
|
REUN
|
Reunion Neuroscience Inc.
|
US
|
NASDAQ
|
|
RLMD
|
Relmada Therapeutics, Inc.
|
US
|
NASDAQ
|
|
BLOZF
|
Cannabix Technologies Inc
|
US
|
OTC
|
|
DRNK
|
NOHO, Inc
|
US
|
OTC
|
|
ESNR
|
Electronic Senor Tec
|
US
|
OTC
|
|
KONEF
|
Ketamineone Capital Ltd
|
US
|
OTC
|
|
NRXCF
|
Neutrisci International
|
US
|
OTC
|
|
WYPH
|
Waypoint Biomed Hldgs Inc
|
US
|
OTC
|
|
AQS
|
Aequus Pharmaceuticals Inc.
|
CA
|
TSXV
|
|
IPCI
|
Intellipharmaceutics International Inc.
|
CA
|
TSX
|
|
OKYO
|
Okyo Pharma Corporation
|
UK
|
LSE
|